Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trial
収録刊行物
-
- European Journal of Cancer
-
European Journal of Cancer 51 (10), 1274-1282, 2015-07
Elsevier BV